医学
胰岛素瘤
分级(工程)
重症监护医学
梅德林
内窥镜检查
医学物理学
内镜治疗
内镜治疗
普通外科
证据质量
临床实习
上内镜检查
干预(咨询)
医学诊断
神经内分泌肿瘤
协商一致会议
生活质量(医疗保健)
质量评定
医学文献
质量保证
病人护理
作者
Shaomei Tang,Qinglin He,Wei Luo,Sibiao Su,Zhuo Yang,Aiming Yang,Enqiang Linghu,Zhendong Jin,Shanyu Qin
标识
DOI:10.1097/eus.0000000000000222
摘要
Insulinoma is a rare functional pancreatic neuroendocrine tumor characterized by excessive insulin secretion, which causes hypoglycemia. Recent advances in endoscopic technology have provided essential tools for the diagnosis and treatment of insulinoma. Early diagnosis and timely intervention, particularly endoscopy-guided intervention in selected patients, may improve clinical outcomes and quality of life. Although existing national and international guidelines mention insulinoma, standardized criteria for its endoscopic diagnosis and treatment remain lacking. Therefore, under the leadership of the Digestive Endoscopy Branch of the Chinese Medical Association, experts from related fields were invited to develop the Expert Consensus on Endoscopic Diagnosis and Treatment for Insulinoma (2026). The development process included a comprehensive review of recent national and international evidence-based literature, with the quality of evidence and strength of recommendations assessed according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. This consensus emphasizes endoscopy-guided diagnostic and therapeutic approaches. It aims to provide practical recommendations and operational guidance for standardized endoscopic diagnosis and treatment of insulinoma, thereby advancing the quality of endoscopic care for this condition in China.
科研通智能强力驱动
Strongly Powered by AbleSci AI